- StageZero Life Sciences Ltd. (SZLS) announces the availability of its BORDERPASS™ COVID-19 RT-PCR saliva test
- The BORDERPASS™ kit allows travelers to collect their COVID PCR saliva sample from the comfort of their home, office, or hotel room
- Saliva samples are self-collected by travelers under video supervision of a healthcare professional using Ichor Blood Services’ video conferencing capabilities
- Travelers then simply request FedEx to pick up their sample to deliver to the StageZero laboratory in provided packaging
- Test results are delivered via email within 24 hours of the lab receiving the sample
- StageZero Life Sciences Ltd. (SZLS) is up 1.93 per cent trading at $0.26 per share as of 2:14 p.m. ET
StageZero Life Sciences Ltd. (SZLS) announces the availability of its BORDERPASS™ COVID-19 RT-PCR saliva test.
The BORDERPASS™ kit allows travellers to collect their COVID PCR saliva sample from the comfort of their home, office, or hotel room.
The BORDERPASS™ RT-PCR saliva test makes it easy and convenient for travellers to take their COVID PCR test without scrambling to find a PCR clinic when they are on the road.
BORDERPASS™PCR test results are accepted at Canadian and most international borders and offer one-way and two-way test kits for travellers departing from the U.S. or Canada.
Saliva samples are self-collected by travellers under the video supervision of a healthcare professional using Ichor Blood Services’ video conferencing capabilities.
Travellers then request FedEx to pick up their sample to deliver to the StageZero laboratory in provided packaging.
Test results are delivered via email within 24 hours of the lab receiving the sample.
BORDERPASS™ test kits for individuals and businesses are available for purchase online and at stores across Canada.
According to today’s expected announcement, Canada will continue to require that all non-Canadians and citizens who have been outside the country for over 72 hours present a negative COVID PCR test to enter the country.
International travel is quickly heating up with the easing of travel restrictions between the U.S. and Canada.
StageZero began offering COVID-19 tests in April 2020.
StageZero Life Sciences Ltd. (SZLS) is up 1.93 per cent trading at $0.26 per share as of 2:14 p.m. ET.